{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPTP4A3 (also known as PRL-3) has emerged as a key oncogenic protein tyrosine phosphatase whose expression is markedly elevated in metastatic lesions relative to primary tumors or normal tissues. This overexpression has been reported in a spectrum of human malignancies—including colorectal, gastric, ovarian, breast, uveal melanoma, multiple myeloma, hepatocellular carcinoma, glioma, and nasopharyngeal carcinoma—and is strongly associated with enhanced invasive behavior, lymphatic and distant spread, and ultimately poorer patient prognosis. These studies have also led to the development of diagnostic tools such as specific monoclonal antibodies to detect PRL-3 in metastatic settings."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "18"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMechanistically, PTP4A3 functions as a dual‐specificity phosphatase with a uniquely hydrophobic and flexible active site that enables it to dephosphorylate key substrates and thereby modulate cell signaling. Experimental and structural studies have shown that PRL-3 can directly dephosphorylate cytoskeletal and adhesion-associated proteins—for example, Ezrin (at Thr567), keratin 8, and proteins that regulate microtubule dynamics such as stathmin—to promote rearrangements of the actin cytoskeleton and focal adhesion turnover. In parallel, alterations in signaling cascades involving AKT, ERK, Src, and PI3K, as well as the modulation of epithelial-to-mesenchymal transition (EMT) via GSK3β inhibition and cadherin downregulation, further underline PRL-3’s role in enhancing cell motility, invasion, and survival. In addition, posttranscriptional regulation by factors such as PCBP1 and microRNAs (both those suppressed by and induced via PRL-3 activity) adds an extra layer of control to its oncogenic signaling."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "19", "end_ref": "36"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional regulatory inputs further refine PRL-3’s oncogenic functions and present attractive avenues for therapeutic intervention. Upstream, PRL-3 expression is modulated by microRNAs—which in certain contexts become silenced by DNA hypermethylation—and is transcriptionally driven by pathways such as FLT3-STAT3 and IL6-mediated signaling. Moreover, deubiquitinating enzymes like USP4 have been shown to stabilize PRL-3 protein levels, while PRL-3 itself may downregulate tumor suppressors such as PTEN to facilitate PI3K/AKT pathway activation. These mechanisms not only amplify downstream signals that promote focal adhesion reorganization, angiogenesis (via enhanced VEGF signaling) and autophagic flux but also contribute to drug resistance in cancers such as acute myeloid leukemia and triple-negative breast cancer. Collectively, these insights underscore the potential of targeting PRL-3 or its regulatory network as a means to curb metastasis and improve clinical outcomes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "37", "end_ref": "42"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "S Saha, A Bardelli, P Buckhaults, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A phosphatase associated with metastasis of colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1065817"}], "href": "https://doi.org/10.1126/science.1065817"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11598267"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11598267"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Alberto Bardelli, Saurabh Saha, Jason A Sager, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRL-3 expression in metastatic cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2003)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14654542"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14654542"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Xiaopeng Wu, Hu Zeng, Xianming Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S0002-9440(10)63763-7"}], "href": "https://doi.org/10.1016/S0002-9440(10"}, {"type": "t", "text": "63763-7) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15161639"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15161639"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Hirotaka Kato, Shuho Semba, Upik A Miskad, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-04-0485"}], "href": "https://doi.org/10.1158/1078-0432.CCR-04-0485"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15534108"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15534108"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Jie Li, Ke Guo, Vicki Wei Chyi Koh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-04-1984"}], "href": "https://doi.org/10.1158/1078-0432.CCR-04-1984"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15788667"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15788667"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Federica Polato, Annamaria Codegoni, Robert Fruscio, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRL-3 phosphatase is implicated in ovarian cancer growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-04-2357"}], "href": "https://doi.org/10.1158/1078-0432.CCR-04-2357"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16203771"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16203771"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "I Radke, M Götte, C Kersting, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.bjc.6603261"}], "href": "https://doi.org/10.1038/sj.bjc.6603261"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16832410"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16832410"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "L Wang, L Peng, B Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Oncol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/annonc/mdl159"}], "href": "https://doi.org/10.1093/annonc/mdl159"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16873432"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16873432"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Ke Guo, Jie Li, Haihe Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-06-0726"}], "href": "https://doi.org/10.1158/0008-5472.CAN-06-0726"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17018620"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17018620"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Ying Wang, Zhao-Fa Li, Jin He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Colorectal Dis (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00384-007-0303-1"}], "href": "https://doi.org/10.1007/s00384-007-0303-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17440740"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17440740"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Unn-Merete Fagerli, Randi U Holt, Toril Holien, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2007-07-101139"}], "href": "https://doi.org/10.1182/blood-2007-07-101139"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17934070"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17934070"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Lingfei Kong, Qing Li, Lifu Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropathology (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1440-1789.2007.00818.x"}], "href": "https://doi.org/10.1111/j.1440-1789.2007.00818.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18021371"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18021371"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Wen-Bo Zhao, Ying Li, Xin Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2008)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18636172"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18636172"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Jun Zhou, Shuang Wang, Juan Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.24096"}], "href": "https://doi.org/10.1002/ijc.24096"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19101992"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19101992"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Xiaofang Xing, Lirong Peng, Like Qu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic value of PRL-3 overexpression in early stages of colonic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histopathology (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2559.2009.03226.x"}], "href": "https://doi.org/10.1111/j.1365-2559.2009.03226.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19236507"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19236507"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Ni Dai, Ai-Ping Lu, Cheng-Chao Shou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "World J Gastroenterol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3748/wjg.15.1499"}], "href": "https://doi.org/10.3748/wjg.15.1499"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19322925"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19322925"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Cécile Laurent, Fabien Valet, Nathalie Planque, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-10-0605"}], "href": "https://doi.org/10.1158/0008-5472.CAN-10-0605"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21135111"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21135111"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Caiyun Liu, Like Qu, Bin Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Combined phenotype of 4 markers improves prognostic value of patients with colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Sci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MAJ.0b013e31822cb4cd"}], "href": "https://doi.org/10.1097/MAJ.0b013e31822cb4cd"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22261620"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22261620"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Kyoung-Ah Kim, Jin-Sue Song, JunGoo Jee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure of human PRL-3, the phosphatase associated with cancer metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2004.03.062"}], "href": "https://doi.org/10.1016/j.febslet.2004.03.062"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15135076"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15135076"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Lirong Peng, Genglin Jin, Li Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2006.01.102"}], "href": "https://doi.org/10.1016/j.bbrc.2006.01.102"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16472776"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16472776"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Cecile Rouleau, Andre Roy, Thia St Martin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-05-0289"}], "href": "https://doi.org/10.1158/1535-7163.MCT-05-0289"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16505094"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16505094"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Eleonora Forte, Laura Orsatti, Fabio Talamo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamcr.2007.11.004"}], "href": "https://doi.org/10.1016/j.bbamcr.2007.11.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18078820"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18078820"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Eri Mizuuchi, Shuho Semba, Yoshinori Kodama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.24111"}], "href": "https://doi.org/10.1002/ijc.24111"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19115206"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19115206"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Yuhong Liu, Jun Zhou, Juanzhi Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRL-3 promotes epithelial mesenchymal transition by regulating cadherin directly."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biol Ther (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cbt.8.14.8695"}], "href": "https://doi.org/10.4161/cbt.8.14.8695"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19440036"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19440036"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Haihe Wang, Leah A Vardy, Cheng Peow Tan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2010.04.028"}], "href": "https://doi.org/10.1016/j.ccr.2010.04.028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20609352"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20609352"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Ping Zheng, Yong-Xia Liu, Lin Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Proteome Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/pr100712t"}], "href": "https://doi.org/10.1021/pr100712t"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20806969"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20806969"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Yanjun Jiang, Xiao-Qiong Liu, Ashwani Rajput, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphatase PRL-3 is a direct regulatory target of TGFbeta in colon cancer metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-10-1487"}], "href": "https://doi.org/10.1158/0008-5472.CAN-10-1487"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21084277"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21084277"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Jianbiao Zhou, Chonglei Bi, Wee-Joo Chng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-AML therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0019798"}], "href": "https://doi.org/10.1371/journal.pone.0019798"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21589872"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21589872"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Victoria McParland, Giulia Varsano, Xun Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositides."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi201095z"}], "href": "https://doi.org/10.1021/bi201095z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21806020"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21806020"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Pablo Rios, Xun Li, Maja Köhn "}, {"type": "b", "children": [{"type": "t", "text": "Molecular mechanisms of the PRL phosphatases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1742-4658.2012.08565.x"}], "href": "https://doi.org/10.1111/j.1742-4658.2012.08565.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22413991"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22413991"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Zhengrong Li, Yi Cao, Zhigang Jie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2012.03.029"}], "href": "https://doi.org/10.1016/j.canlet.2012.03.029"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22469786"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22469786"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "J Zhang, Z Xiao, D Lai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/bjc.2012.251"}], "href": "https://doi.org/10.1038/bjc.2012.251"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22677902"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22677902"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Jung Eun Park, Hiu Fung Yuen, Jian Biao Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO Mol Med (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/emmm.201202183"}], "href": "https://doi.org/10.1002/emmm.201202183"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23929599"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23929599"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Mark W Zimmerman, Kelley E McQueeney, Jeffrey S Isenberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M113.480038"}], "href": "https://doi.org/10.1074/jbc.M113.480038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24403062"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24403062"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Heyang Xu, Wei Lai, Yang Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-14-330"}], "href": "https://doi.org/10.1186/1471-2407-14-330"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24885636"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24885636"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Yu-Han Huang, Abdul Qader O Al-Aidaroos, Hiu-Fung Yuen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A role of autophagy in PTP4A3-driven cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Autophagy (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/auto.29989"}], "href": "https://doi.org/10.4161/auto.29989"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25136802"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25136802"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Zhengrong Li, Guoyang Zhang, Daojiang Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methylation-associated silencing of miR-495 inhibit the migration and invasion of human gastric cancer cells by directly targeting PRL-3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2014.11.083"}], "href": "https://doi.org/10.1016/j.bbrc.2014.11.083"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25475733"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25475733"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Cheng Xing, Xing-Xing Lu, Peng-Da Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-14-3595"}], "href": "https://doi.org/10.1158/0008-5472.CAN-14-3595"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26669864"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26669864"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Hamid H Gari, Gregory D DeGala, Rahul Ray, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2016.07.017"}], "href": "https://doi.org/10.1016/j.canlet.2016.07.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27452906"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27452906"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Jianbo Xiong, Zhengrong Li, Yang Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2016.5030"}], "href": "https://doi.org/10.3892/or.2016.5030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27572739"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27572739"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Huizhi Zhang, Guennadi Kozlov, Xinlu Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-00147-2"}], "href": "https://doi.org/10.1038/s41598-017-00147-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28246390"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28246390"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Phyllis S Y Chong, Jianbiao Zhou, Julia S L Lim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-19-0343"}], "href": "https://doi.org/10.1158/0008-5472.CAN-19-0343"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31337650"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31337650"}]}]}]}